BGIM
CLOVW

Boussard & Gavaudan Investment Management’s Clover Health Investments, Corp. Warrants CLOVW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CLOVW Stock Details CLOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-216,666
Closed -$877K – 106
2020
Q4 		$877K Hold
216,666
– – 0.12% 40
2020
Q3 		$849K Buy
+216,666
New +$678K 0.11% 38

Other funds holding CLOVW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.02% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CLOVW Position: Q1 2021 in Review

Boussard & Gavaudan Investment Management sold out of Clover Health Investments, Corp. Warrants (CLOVW) in Q1 2021, closing a stake of 216,666 shares — an estimated $877K sold.

Boussard & Gavaudan Investment Management first reported a position in CLOVW in Q3 2020 and held it in 2 quarters. The position peaked at $877K in Q4 2020. 36 funds tracked by Wall St. Rank hold CLOVW as of Q1 2021.

  • Boussard & Gavaudan Investment Management reported no remaining Clover Health Investments, Corp. Warrants position as of Q1 2021 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 216,666 Clover Health Investments, Corp. Warrants shares in Q1 2021, an estimated $877K.
  • Boussard & Gavaudan Investment Management first reported a position in Clover Health Investments, Corp. Warrants in Q3 2020 and held it in 2 quarters.
  • Boussard & Gavaudan Investment Management's Clover Health Investments, Corp. Warrants position peaked at $877K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Clover Health Investments, Corp. Warrants as of Q1 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2021, filed 11 May 2021.